The DCM-Et2O solvated title compound, [CoCl2(C30H31NP2)2][Co2(C12H10O2P)3Cl2]·1.189CH2Cl2·0.811C4H10O or [CoCl2{Ph2PN(C6H11)PPh2}2][Co2{Ph2PO2}3Cl2]·1.189DCM·0.811Et2O, is a combination of a cationic CoIII-amino-diphosphine and a dimetallic CoII-di-phenyl-phospho-nate anionic species. The asymmetric unit features one half of the cationic and anionic species with solvent mol-ecules in the outer coordination sphere. The metal centre of the cation is located on an inversion center, while the anion is disordered around an inversion center. The cyclo-hexa-nyl moiety of the amino-diphosphine ligand exhibits two-component rotational disorder along the N-C bond, the moiety's major component occupancy refined to 71.1 (7)%. The di-chloro-methane and diethyl ether solvate mol-ecules are disordered with each other and were modelled with 59.4 (3)% and 40.6 (3)% site occupancies in the asymmetric unit, respectively. Inter-molecular C-H⋯π hydrogen-bonding patterns form infinite supra-molecular sheets extending parallel to (110). C-H⋯Cl and C-H⋯O hydrogen bonds were also found in the crystal packing of the title compound.
No takes yet. Share an insight, caveat, or question.
Zamisa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: